Thoracic Oncology Trials Team Shortlisted for Oncology Team of the Year 

25 September 2025

The Thoracic Oncology Trials Team at Velindre Cancer Centre have been selected as finalists for the ‘Oncology Team of the Year’ Award at the Welsh Healthcare Awards 2025.

Led by Dr Paul Shaw, the nomination recognises the whole lung research team and highlights the remarkable collective effort that has gone into expanding and enhancing Velindre’s lung research portfolio in recent years.

The award application highlighted the importance of collaboration not only within the Thoracic Oncology Trials Team, but also across departments, disciplines, and partner organisations within all of our research efforts.

This achievement reflects the dedication and collaboration across multiple departments, including:

• R&D
• Research Administration
• Research Nurses (Early & Late Phase)
• Pharmacy
• Radiotherapy Research Radiographers
• Radiology
• RT Pathways
• Medical Physics
• Clinical & Medical Oncology
• Principal & Chief Investigators
• Lung MDT CNSs
• AHP Medical Prescribers
• Industry Partners
• Digital Teams
• Health Board Clinicians

Velindre Cancer Centre has transformed lung cancer care by expanding access to clinical trials that offer patients innovative, personalised treatment options. Our multidisciplinary team ensures patients across South Wales benefit from cutting-edge therapies - including immunotherapy, radiotherapy, and liquid biopsy diagnostics - delivered with compassion and precision. 

Trials such as CRUK-CONCORDE (early phase drug RT trial in stage 3 NSCLC) and HITMESO (radical proton therapy in hemithoracic pleural mesothelioma) studies have improved access for patients with complex disease, while studies like TOURIST (palliative RT in NSCLC) and QuicDNA enhance palliative therapy. Patients report feeling more informed, supported, and empowered, with research participation offering hope and a sense of purpose during a difficult time. 

Seamless integration of trials into care pathways, supported by future digital tools and strong partnerships, will ensure minimal disruption and maximum benefit. Our team’s dedication has positioned Velindre as a trusted national referral centre, where research excellence directly translates into improved patient experience, outcomes, and quality of life.